Lucira Health akcijos akcijų analizė | Akcijų kaina | Naujienos | LHDXQ | US54948U1051 |

Data	Lucira Health Akcijų kaina
2023-10-04	0,00 USD
2023-10-03	0,00 USD

Data	Lucira Health Pajamos	Lucira Health EBIT	Lucira Health Pelnas
2023e	128,75 mln. USD	−32,19 mln. USD	−24,25 mln. USD
2022e	228,92 mln. USD	−156,81 mln. USD	−9,62 mln. USD
2021	93,06 mln. USD	−57,20 mln. USD	−64,83 mln. USD
2020	269 000,00 USD	−31,93 mln. USD	−37,35 mln. USD

	Pajamos	EBIT	Pelnas
2020	269 000,00 USD	−31,93 mln. USD	−37,35 mln. USD
2021	93,06 mln. USD	−57,20 mln. USD	−64,83 mln. USD
2022e	228,92 mln. USD	−156,81 mln. USD	−9,62 mln. USD
2023e	128,75 mln. USD	−32,19 mln. USD	−24,25 mln. USD

2020	2021	2022e	2023e
0	93,00	228,00	128,00
-	-	145,16	−43,86
-	19,35	-	-
−1,00	18,00	0	0
−31,00	−57,00	−156,00	−32,00
-	−61,29	−68,42	−25,00
−37,00	−64,00	−9,00	−24,00
-	72,97	−85,94	166,67
36,96	34,77	0	0
-	-	-	-

2019	2020	2021

4,10	58,21	105,98
0	0,29	27,25
0	0,18	8,19
0	4,87	50,78
0,24	6,68	14,09
4,34	70,23	206,28
1,43	20,16	33,69
0	0	0
0	0	0
0	0	0
0	0	0
0,05	2,32	0,38
1,47	22,47	34,07
5,81	92,70	240,35

30,97	121,08	0,04
0,69	1,40	317,30
−26,37	−63,71	−128,54
0	0	0
0	0	0
5,29	58,77	188,80
0,57	3,98	19,37
1,03	4,88	29,22
0	0	1,74
0	0	0
0	0	0
1,60	8,86	50,33
0	24,69	0
0	0	0
0,71	0,38	1,22
0,71	25,07	1,22
2,31	33,93	51,55
7,61	92,70	240,35

2019	2020	2021
−8,00	−37,00	−64,00
0	0	3,00
0	0	0
0	−3,00	−57,00
1,00	8,00	17,00
0	0	0
0	0	0
−7,00	−32,00	−100,00
0	−18,00	−15,00
0	−18,00	−15,00
0	0	0
0	0	0
0	31,00	0
10,00	76,00	161,00
11,00	107,00	161,00
-	-	-
0	0	0
4,00	56,00	45,00
−7,14	−51,34	−116,27
0	0	0

Lucira Health Bruto marža	Lucira Health Pelnas-martža	Lucira Health EBIT marža	Lucira Health Pelnas-martža
2023e	19,52 %	−25,00 %	−18,84 %
2022e	19,52 %	−68,50 %	−4,20 %
2021	19,52 %	−61,47 %	−69,67 %
2020	−621,56 %	−11 868,03 %	−13 884,02 %

	Bruto marža	EBIT marža	Pelnas-martža
2020	−621,56 %	−11 868,03 %	−13 884,02 %
2021	19,52 %	−61,47 %	−69,67 %
2022e	19,52 %	−68,50 %	−4,20 %
2023e	19,52 %	−25,00 %	−18,84 %

Data	Lucira Health Pardavimai vienai akcijai	Lucira Health EBIT vienai akcijai	Lucira Health Pelnas vienai akcijai
2023e	3,17 USD	0 USD	−0,60 USD
2022e	5,64 USD	0 USD	−0,24 USD
2021	2,68 USD	−1,65 USD	−1,86 USD
2020	0,01 USD	−0,86 USD	−1,01 USD

	Pardavimai vienai akcijai	EBIT vienai akcijai	Pelnas vienai akcijai
2020	0,01 USD	−0,86 USD	−1,01 USD
2021	2,68 USD	−1,65 USD	−1,86 USD
2022e	5,64 USD	0 USD	−0,24 USD
2023e	3,17 USD	0 USD	−0,60 USD

	Akcijų skaičius
2020	36,96 mln. Aktien
2021	34,77 mln. Aktien
2022e	34,77 mln. Aktien
2023e	34,77 mln. Aktien

Data	EPS-prognozė	EPS-Faktinis	Pranešimo ketvirtis
2022-09-30	−0,39 USD	−3,15 USD (−697,87 %)	2022 Q3
2022-06-30	−0,35 USD	−0,45 USD (−28,50 %)	2022 Q2
2022-03-31	−0,08 USD	0,40 USD (585,44 %)	2022 Q1
2021-12-31	−0,56 USD	0,01 USD (101,78 %)	2021 Q4
2021-09-30	−0,53 USD	−0,47 USD (11,10 %)	2021 Q3
2021-06-30	−0,33 USD	−0,38 USD (−15,29 %)	2021 Q2
2021-03-31	−0,34 USD	−0,54 USD (−58,87 %)	2021 Q1

%	Pavadinimas	Akcijos	Pokytis	Data
5,52 %	Yen (Tuff)	2 241 668	−51 334	2022-04-20
15,33 %	Eclipse ventures , LLC	6 223 795	0	2022-12-31
1,79 %	EPIQ Capital Group, LLC	725 675	−13 011 695	2022-12-31
1,54 %	The Vanguard Group, Inc.	623 488	−8 279	2022-12-31
1,08 %	Citi Investment Research (US)	436 840	−181 803	2022-12-31
0,92 %	Mitra (Debkishore)	375 363	−191	2022-09-01
0,76 %	Engelson (Erik T.)	310 241	−60 000	2023-03-03
0,71 %	Boeding (Chad)	288 918	288 918	2022-12-14
0,67 %	Lamond (David A.)	271 666	0	2022-04-20
0,67 %	Balyasny Asset Management LP	271 030	−55 168	2022-12-31
0,51 %	Morgan Stanley Smith Barney LLC	206 489	−5 479	2022-12-31
0,37 %	L. Roy Papp & Associates, LLP	150 699	36 205	2022-12-31
0,33 %	Allen (Anthony Joseph)	133 091	−8 405	2023-03-03
0,28 %	Prashar (Tamanna)	113 372	−248	2022-07-08
0,27 %	Bridgeway Capital Management, LLC	110 500	−14 200	2022-12-31
0,25 %	Hartmann Hansgregory C	100 000	30 000	2021-06-18
0,24 %	Geode Capital Management, L.L.C.	95 621	0	2022-12-31
0,22 %	Consilio Wealth Advisors, LLC	90 199	−7 319	2022-12-31
0,19 %	Narido (Richard Clavano)	77 910	−29 383	2023-03-07
0,18 %	IEQ Capital LLC	74 095	0	2022-12-31
0,17 %	Virtu Americas LLC	68 179	68 179	2022-12-31
0,12 %	Collins (Kevin Walter)	48 991	−9 666	2022-11-27
0,10 %	George (Daniel)	41 989	−343	2022-09-18
0,10 %	BlackRock Institutional Trust Company, N.A.	39 716	920	2022-12-31
0,08 %	Tudor Investment Corporation	31 002	0	2022-12-31
0,08 %	State Street Global Advisors (US)	30 507	0	2022-12-31
0,07 %	Renaissance Technologies LLC	29 000	29 000	2022-12-31
0,07 %	Jane Street Capital, L.L.C.	26 831	26 831	2022-12-31
0,06 %	Resolute Partners Group	22 800	0	2022-12-31
0,04 %	Buckingham Strategic Partners, LLC	17 857	17 857	2022-12-31
0,04 %	Northern Trust Investments, Inc.	17 414	0	2022-12-31
0,04 %	PGIM Quantitative Solutions LLC	17 200	0	2022-12-31
0,03 %	Tower Research Capital LLC	12 972	9 422	2022-12-31
0,03 %	RBC Dominion Securities, Inc.	11 660	0	2022-12-31
0,03 %	TrinityPoint Wealth LLC	11 000	0	2022-12-31
0,03 %	BlackRock Financial Management, Inc.	10 403	0	2022-12-31
0,02 %	Wells Fargo Advisors	10 000	−500	2022-12-31
0,01 %	Group One Trading, L.P.	4 752	−11 019	2022-12-31
0,01 %	Dimensional Fund Advisors, L.P.	3 487	0	2022-12-31
0,01 %	BlackRock Investment Management, LLC	3 087	0	2022-12-31
0,01 %	Lord, Abbett & Co. LLC	3 087	0	2023-01-31
0,01 %	Kashmolah (Ghazi)	2 591	−194 649	2022-04-20
0,00 %	Morgan Stanley & Co. LLC	1 266	1 080	2022-12-31
0,00 %	J.P. Morgan Securities LLC	1 100	1 092	2022-12-31
0,00 %	Simplex Trading, LLC	1 099	−18 558	2022-12-31
0,00 %	Wells Fargo Bank, N.A.	109	3	2022-12-31
0,00 %	BofA Global Research (US)	19	19	2022-12-31
0 %	Marshall Wace LLP	0	−41 366	2021-06-30
0 %	AQR Capital Management, LLC	0	−3 958	2021-06-30
0 %	Millennium Management LLC	0	−29 436	2022-09-30
0 %	ProFund Advisors LLC	0	−227	2021-07-31
0 %	Needham Investment Management L.L.C.	0	−13 672	2021-12-31
0 %	Citadel Advisors LLC	0	−35 544	2022-03-31
0 %	Davidson Kempner Capital Management LP	0	−30 000	2021-06-30
0 %	D. E. Shaw & Co., L.P.	0	−13 866	2022-09-30
0 %	Charles Schwab Investment Management, Inc.	0	−36 397	2021-09-30
0 %	Pictet Asset Management Ltd.	0	−122 112	2021-06-30
0 %	BlackRock Investment Management (UK) Ltd.	0	−4 517	2021-06-30
0 %	Legal & General Investment Management Ltd.	0	−1 054	2021-06-30
0 %	BlackRock Advisors (UK) Limited	0	−304	2021-06-30
0 %	BlackRock (Netherlands) B.V.	0	−19 055	2021-06-30
0 %	Vaughan Nelson Investment Management, L.P.	0	−771	2021-06-30
0 %	Principal Global Investors (Equity)	0	−4 384	2022-04-30
0 %	T. Rowe Price Associates, Inc.	0	−17 400	2022-09-30
0 %	State Teachers Retirement System of Ohio	0	−2 500	2021-06-30
0 %	Morgan Stanley Investment Management Inc. (US)	0	−96	2021-09-30
0 %	Manulife Investment Management (North America) Limited	0	−556	2022-12-31
0 %	SunAmerica Asset Management, LLC	0	−6 089	2021-06-30
0 %	Howe and Rusling, Inc.	0	−200	2021-09-30
0 %	Goldman Sachs & Company, Inc.	0	−39 872	2021-06-30
0 %	U.S. Bancorp Asset Management, Inc.	0	−40	2021-12-31
0 %	Fidelity Management & Research Company LLC	0	−57 234	2021-12-31
0 %	Nuveen LLC	0	−16 911	2021-06-30
0 %	JPMorgan Private Bank (United States)	0	−135 495	2021-06-30
0 %	Ameritas Investment Partners, Inc.	0	−850	2021-06-30
0 %	BNY Mellon Asset Management	0	−21 969	2021-06-30
0 %	Paloma Partners Management Company	0	−13 084	2022-03-31
0 %	Numeric Investors LLC	0	−10 400	2022-06-30
0 %	Federated Hermes Global Investment Management Corp.	0	−509 756	2021-06-30
0 %	BMO Capital Markets (US)	0	−358	2021-06-30
0 %	Westfield Capital Management Company, L.P.	0	−434	2021-06-30
0 %	New York State Common Retirement Fund	0	−96	2021-09-30
0 %	California State Teachers Retirement System	0	−15 758	2021-06-30
0 %	JP Morgan Asset Management	0	−150 194	2021-06-30
0 %	Franklin Mutual Advisers, LLC	0	−598	2021-06-30
0 %	UBS Financial Services, Inc.	0	−4 877	2022-12-31
0 %	Choice Wealth Advisors, LLC	0	−97 518	2022-09-30
0 %	Cypress Point Wealth Management, LLC	0	−39 000	2022-12-31
0 %	Castleknight Management LP	0	−66 700	2022-09-30
0 %	LifeSci Fund Management LLC	0	−320 200	2022-12-31
0 %	CaaS Capital Management LP	0	−30 000	2021-06-30
0 %	BioImpact Capital LLC	0	−578 114	2021-12-31
0 %	Maven Investment Partners US Ltd.	0	−25 000	2021-06-30
0 %	Logos Global Management LLC	0	−250 000	2021-06-30
0 %	DCVC Management Co, LLC	0	−296 227	2022-03-31
0 %	Atom Investors LP	0	−85 921	2022-06-30
0 %	Walleye Capital LLC	0	−10 915	2022-03-31
0 %	Parian Global Management LP	0	−183 804	2022-03-31
0 %	Mellon Investments Corporation	0	−1 966	2021-06-30
0 %	Qube Research & Technologies Ltd	0	−58 790	2022-06-30

What values and corporate philosophy does Lucira Health represent?

Lucira Health Inc represents key values such as innovation, efficiency, and quality in the healthcare industry. The company aims to revolutionize healthcare by developing convenient and accessible diagnostic solutions. With a focus on empowering individuals to take charge of their health, Lucira Health Inc has a strong corporate philosophy centered around enhancing patient outcomes and improving overall well-being. By leveraging cutting-edge technology and expertise, Lucira Health Inc strives to provide accurate and timely diagnostic tools that can be easily used at home or in point-of-care settings.

In which countries and regions is Lucira Health primarily present?

Lucira Health Inc is primarily present in the United States.

What significant milestones has the company Lucira Health achieved?

Lucira Health Inc has achieved several significant milestones. Firstly, in November 2020, the company received Emergency Use Authorization (EUA) from the FDA for its COVID-19 All-In-One Test Kit, becoming the first prescription, at-home molecular diagnostic test for COVID-19. This milestone marked a breakthrough in accessible and accurate testing during the pandemic. Additionally, Lucira Health Inc expanded its distribution partnership with the global pharmaceutical company, GlaxoSmithKline, in March 2021. This collaboration aimed to increase the availability of Lucira's COVID-19 at-home test kits in the United States. These milestones highlight Lucira Health Inc's commitment to innovative, convenient, and reliable diagnostic solutions.

What is the history and background of the company Lucira Health?

Lucira Health Inc is a leading healthcare company specializing in providing innovative, accessible, and reliable diagnostic testing solutions. Established in [year], Lucira Health has a strong emphasis on developing rapid molecular diagnostic tests for various infectious diseases. The company's commitment to revolutionizing healthcare has resulted in the development of its FDA-authorized Lucira™ COVID-19 All-In-One Test Kit, which offers individuals the convenience of at-home testing. Lucira Health's groundbreaking technology aims to improve patient outcomes and access to accurate diagnostics. With a focus on delivering efficient and reliable solutions, Lucira Health continues to make strides in the field of healthcare diagnostics.

Who are the main competitors of Lucira Health in the market?

The main competitors of Lucira Health Inc in the market include companies like Abbott Laboratories, Quidel Corporation, and Becton, Dickinson and Company (BD).

In which industries is Lucira Health primarily active?

Lucira Health Inc is primarily active in the healthcare industry.

What is the business model of Lucira Health?

The business model of Lucira Health Inc. revolves around providing accessible and convenient diagnostic testing solutions. Lucira Health Inc. specializes in developing and manufacturing innovative at-home rapid molecular testing platforms for various infectious diseases, including COVID-19. Through their proprietary technologies, Lucira Health Inc. enables individuals to easily detect and monitor their health conditions in the comfort of their own homes. Their user-friendly testing kits deliver accurate results within a short timeframe, promoting early intervention and timely treatment. Lucira Health Inc.'s business model aims to empower individuals, healthcare providers, and public health agencies by offering reliable and cost-effective testing solutions.

Koks yra Lucira Health 2024 KGV?

P/E santykio šiuo metu Lucira Health apskaičiuoti negalima.

Koks Lucira Health 2024 KUV?

KUV šiuo metu negali būti apskaičiuotas Lucira Health.

Koks yra Lucira Health AlleAktien kokybės įvertinimas?

AlleAktien kokybės įvertis Lucira Health yra 2/10.

Koks yra Lucira Health 2024 pajamų dydis?

Pajamos šiuo metu negali būti apskaičiuotos Lucira Health.

Kokia yra Lucira Health 2024 pelnas?

Pelnas šiuo metu negali būti apskaičiuotas Lucira Health.

Ką daro Lucira Health?

Lucira Health Inc is a US-based company that offers medical devices and solutions in the field of in-vitro diagnostics. The company focuses on the needs of consumers and healthcare facilities and provides innovative solutions for conducting tests for various diseases and conditions quickly, easily, and reliably. Their business model encompasses the development, manufacturing, and marketing of diagnostic and monitoring solutions for a wide range of medical conditions, including HIV, hepatitis, and COVID-19. Their main product is a home-use COVID-19 test kit, which was approved by the FDA in November 2020. They also offer other products, such as a home-use rapid influenza test, as well as diagnostic solutions for hemoglobin, bilirubin, and glucose. Lucira Health Inc markets and distributes its products through various channels, including direct sales to healthcare facilities and online marketplaces like Amazon and Walmart. They have also signed an agreement with Grifols, a leading biotechnology company, to distribute their products in Europe and Latin America. The company collaborates closely with clinical partners and research institutions to develop and improve their products and solutions. Lucira Health Inc is well-positioned to grow and thrive in the in-vitro diagnostics market, thanks to its emphasis on collaboration and innovation.

Kokia yra Lucira Health dividendė?

Lucira Health moka dividendą 0 USD, kuris yra paskirstytas per išmokas per metus.

Kiek kartų Lucira Health moka dividendą?

Dividenda šiuo metu negali būti apskaičiuota Lucira Health arba įmonė dividendų nemoka.

Kas yra Lucira Health ISIN?

Lucira Health ISIN yra US54948U1051.

Kas yra Lucira Health Tickeris?

Lucira Health akcijų simbolis yra LHDXQ.

Kiek dividendų moka Lucira Health?

Per paskutinius 12 mėnesių Lucira Health išmokėjo dividendą, kurios dydis siekė . Tai atitinka maždaug dividendų grąžą. Artimiausiems 12 mėnesiams Lucira Health tikėtina išmokės dividendus, kurie sudarys 0 USD.

Kokia yra Lucira Health dividendų grąža?

Lucira Health šiuo metu yra dydžio dividendų grąža.

Kada Lucira Health moka dividendus?

Lucira Health moka dividendus kas ketvirtį. Jie išmokami mėnesiais.

Kokia saugi yra Lucira Health dividendų išmokėjimas?

Lucira Health per paskutiniuosius 0 metus kiekvienais metais mokėjo dividendus.

Kokia yra Lucira Health dividendų suma?

Artimiausiems 12 mėnesiams tikimasi dividendų, kurių dydis yra 0 USD. Tai atitinka 0 % dividendų grąžos procentą.

Kokiame sektoriuje yra Lucira Health?

Lucira Health priskiriamas sektoriui "Sveikata".

Wann musste ich die Aktien von Lucira Health kaufen, um die vorherige Dividende zu erhalten?

Norėdamas gauti paskutinį Lucira Health dividendą nuo 2024-09-07, kurio dydis yra 0 USD, turėjai turėti akciją savo depozite prieš ex-dieną, kuri buvo 2024-09-07.

Kada Lucira Health paskutinį kartą mokėjo dividendą?

Paskutinės dividendų išmokėjimas įvyko 2024-09-07.

Kokia buvo Lucira Health dividendų suma 2023 metais?

2023 metais Lucira Health išmokėjo 0 USD dividendų.

Kokia valiuta Lucira Health moka dividendus?

Lucira Health dividendai yra mokami USD.

Padaryk geriausias savo gyvenimo investicijas fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Kursas

Akcijos kaina

Akcijų kodasLHDXQ

ISINUS54948U1051

Lucira Health akcijų kaina

Kursas

Apžvalga

Intraday funkcija

Bendroji grąža ir santykinė kainų pokyčiai

Interpretacija ir investavimas

Lucira Health Akcijų istorija

Lucira Health akcijų apyvarta, EBIT, pelnas US54948U1051 ·

Pajamos, pelnas & EBIT

Supratimas apie pajamas, EBIT ir pelną

Metinė analizė ir palyginimai

Išnaudoti lūkesčius investuojant

Investicijų įžvalgos

Lucira Health Pajamų, pelno ir EBIT istorija.

Lucira Health Akcijų rodikliai

GuV

Pajamos ir augimas

Bruto marža

EBIT ir EBIT marža

Pajamos ir jų augimas

Leidžiamų akcijų skaičius

Metinių duomenų palyginimo interpretacija

Lūkesčiai ir prognozės

Balansas

Balanso supratimas

Turtas

Įsipareigojimai

Nuosavas kapitalas

Metų po metų analizė

Duomenų interpretacija

Lucira Health Akcijos Maržos US54948U1051 ·

Margen

Supratimas apie bruto maržą

EBIT maržos analizė

Pardavimų maržos įžvalgos

Lūkesčių interpretavimas

Lyginamoji analizė

Lucira Health Maržų istorija

Lucira Health akcijos apyvarta, EBIT, pelnas vienai akcijai US54948U1051 ·

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

Lucira Health Pardavimų, pelno ir EBIT istorija vienai akcijai

Lucira Health akcija ir akcijų analizė

Lucira Health vertinimas pagal Fair Value

Fair Value

Supratimas apie Fair Value

Pajamų pagrindu skaičiuojamas Fair Value

Apyvartos pagrindu skaičiuojamas Fair Value

Dividendų pagrindu skaičiuojamas Fair Value

Lūkesčiai ir prognozės

Palyginamoji analizė

Lucira Health įvertinimas pagal istorinį P/E, EBIT ir P/S

Lucira Health akcijų skaičius US54948U1051 ·

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

Lucira Health Pelno prognozės

Lucira Health Pelnų staigmenos

Lucira Health akcijos akcininkų struktūra

Lucira Health Valdyba ir Priežiūros taryba

Dažnai užduodami klausimai apie Lucira Health akciją